BERKELEY, CA (UroToday.com) - At any time in North America some 600,000 men are on androgen deprivation therapy (ADT) to treat prostate cancer (PCa).^[1]To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.